ÂÜÀòÂÒÂ×

Mr. Ogilvie joined CardioFocus in 2021 and currently serves as Chief Financial Officer (CFO), leveraging decades of experience in the medical technology sector, including leadership roles in sales, marketing and corporate development, as well as investment banking and sell side equity research. Most recently, he served as Managing Director of Healthcare Investment Banking at B Riley Securities, leading the firm's investment banking advisory engagements with healthcare companies. Previously Mr. Ogilvie served as Vice President, Corporate Development at NuVasive, where he led a variety of key functions, including mergers and acquisitions and the expansion of the company's global sales infrastructure. He has also held medical technology sell-side equity research positions at ThinkEquity Partners and Lazard Capital Markets, and was a product manager at Medtronic. Mr. Ogilvie earned his B.A. from Brigham Young University and his M.B.A. from New York University's Stern School of Business.